OPK 8-K 2026-11-04

OPKO HEALTH, INC. (OPK) 8-K dated 2026-11-04 — accession 0001193125-26-447357.

OPKO HEALTH, INC. (OPK) is a diagnostics & research company listed on US.

OPK: OPKO Health Reports Third Quarter 2026 Business Highlights and Financia…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported OPK revenue for 2026-06-30 was $163.6M. Net income was -$8.4M. Revenue was up 31.7% from 2026-03-31 to 2026-06-30. OPK currently screens at market cap $1.07B.

Not investment advice. The OPK SEC hub lists recent forms. The stock page is the research view.